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Craniofacial genetics makes headway
Studies of neural crest migration in animal models, and of human
syndromes in which craniofacial development is abnormal, are helping
us to understand both prenatal and postnatal development of the head.
At the core of craniofacial research is the desire to under-
stand both normal and abnormal development of the
head. The head has, however, proven to be a particular
challenge to developmental biologists, as many of the
patterning mechanisms are unique to this part of the
body. The clinical genetic approach, studying inherited
syndromes that affect human craniofacial development, is
proving to be very useful for understanding human
dysmorphology and is also providing new directions for
more basic research using animal models.
Patterning the cranial neural crest - moving past the
hindbrain
Neural crest cells play a pivotal role in craniofacial
development, as they initially give rise to most of the
mesenchyme of the head and face, and ultimately the
mesenchyme forms most of the skeletal and connective
tissue in the head. It is thought that many craniofacial
defects arise from perturbations of the neural crest
early in embryonic development. Noden [1], for
example, reported that avian cranial neural crest cells
transplanted from the midbrain - which normally
contribute to the beak - to a more caudal position,
migrated into the neck and gave rise to an extra set
of beaks, thus following their intrinsic developmental
programme. But these results need to be supported
by evidence, at the molecular level, that crar;ial neural
crest cells are informed of their axial level, and of
their ultimate developmental fate, by signals within the
neural tube.
Such molecular evidence is starting to be obtained. The
focus has been on hindbrain neural crest cells, which
make a contribution to the mandible, the cartilage of the
neck and the base of the skull [2,3]. The abundance of
molecular markers and anatomical landmarks - in
particular, the motor nuclei of the cranial nerves - make
the hindbrain an excellent region for developmental
studies. Although there is controversy as to whether all of
the rhombomeres give rise to neural crest cells [4,5],
there is general agreement that, adjacent to rhombomeres
r3 and r5, there are two crest-free regions, and that
neural crest cells maintain this segmental pattern during
their migration into the branchial arches. Neural crest
cells from rhombomeres rl and r2 contribute to the first
branchial arch, whereas more caudally positioned neural
crest cells from r4 and r6 contribute to the second and
third branchial arches, respectively. The first branchial
arch later develops two distinct facial swellings, the
maxillary prominence which contributes to the upper
jaw and the mandibular prominence which forms the
entire lower jaw. The more caudal branchial arches give
rise to cartilages of the neck.
That the hindbrain neural crest is 'prepatterned' has now
been confirmed at the molecular level by Prince and
Lumsden [6]. The homeobox gene Hoxa-2 - one of the
Hox genes that are related to the Drosophila homeotic
selector genes and thought to confer segmental identity
- is normally expressed in a continuous band up to
rhombomere r2, but neural crest cells derived from r2
Fig. 1. The expression of Hoxa-2 (red shading) in a stage 15 chick embryo. (a) A non-manipulated embryo: Hoxa-2 is expressed in the
neural tube up to rhombomere r2 and in the second and third branchial arches. (b) An embryo in which rhombomeres r2 and r3 have
been grafted in the position of r4 and r5: Hoxa-2 is expressed in the neural crest cells emanating from r6 and more caudal regions; only
the third branchial arch contains cells that express Hoxa-2. (c) An embryo in which rhombomeres r4 and r5 have been grafted into the
position of r2 and r3: Hoxa-2 is expressed ectopically in neural crest cells derived from the supernumerary r4 and in the adjacent first
branchial arch mesenchyme.
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factor receptors FGFR-2 [8] and FGFR-3 (my own
group's unpublished results), and the Wnt genes [7,9],
homologues of the Drosophila wingless gene that are
thought to encode cell-cell signalling molecules. In some
cases - such as Wnt-5a [9] - continued expression in
the migrating neural crest and facial mesenchyme can be
seen. The converse is also observed: precise repression of
gene expression in migrating neural crest seems to be
required for distinguishing facial neural crest from those
cells that contribute to more posterior or dorsal struc-
tures [6,10]. Other types of molecule may also be
involved in restricting the fate of neural crest cells, such
as retinoids [11], metalloendopeptidases [12] or new
classes of transcription factors [13]. We may envisage a
role for any or all of these molecules in prepatterning of
the anterior neural crest cells.
Fig. 2. Scanning electron micrograph of 'A' strain mouse
(A/WySn) at developmental stage El 11, by which time the facial
prominences are fully developed. On the right side of the
photograph, a failure of growth of the medial and lateral nasal
prominences has prevented contact between the primordia, and
this will lead to a unilateral cleft lip (arrow). MNP, medial-
nasal prominence; LNP, lateral-nasal prominence; MX,
maxillary prominence; MD, mandibular prominence; 2, second
branchial arch.
stop expressing Hoxa-2 as soon as migration begins, so
that cells in the first branchial arch do not express this
gene (Fig. la). Neural crest cells originating from r4 con-
tinue to express Hoxa-2 during migration and once they
have populated the second branchial arch (Fig. la).
When r2 was transplanted to the r4 position, emigrating
r2 neural crest cells switched off Hoxa-2 expression as
usual, implying that the unusual environment did not
modify their intrinsic developmental programme (Fig.
lb). In the reciprocal experiment, r4-derived neural crest
cells that were moved anterior, to the r2 position,
continued to express Hoxa-2, again ignoring new
environmental cues (Fig. 1c). It should be noted that the
ectopic beaks produced in Noden's chick experiments [1]
were a result of transplanting midbrain neural crest to the
hindbrain, whereas Prince and Lumsden [6] transplanted
small regions entirely within the hindbrain. Moreover,
Prince and Lumsden [6] sacrificed their embryos a short
time after grafting, so that the effects of ectopic gene
expression on cartilage morphogenesis could not be
determined in their experiments.
In contrast to the migratory neural crest cells produced by
the hindbrain, those produced anterior to rhombomere
r3 do not show overt segmentation. Moreover, none of
the 'segment identity' Hox genes is expressed anterior to
rhombomere r2, so other molecules must be involved in
patterning the anterior neural crest. Other molecules have
indeed been reported to show regional patterns of expres-
sion in the neural epithelium of the midbrain and fore-
brain. This is true, for example, of the transcription
factors Otx-2, Pax-6 and En-2 [7], the fibroblast growth
Mapping the non-syndromic cleft lip gene in mice
After neural crest cells have populated the face, the
mesenchyme proliferates and fills the facial prominences.
The correct growth and fusion of the fronto-nasal,
lateral-nasal, medial-nasal and maxillary prominences is
required for normal facial form, and disruption of these
processes leads to facial clefting (Fig. 2). One of the year's
most important advances in the field of craniofacial biol-
ogy will surely be the mapping by Juriloff [14,15] of the
chromosomal location of the mouse gene in which
mutations occur that cause non-syndromic cleft lip.
Despite the availability of suitable mouse models - such
as 'A' strain mice - for decades, it has been extremely
difficult to isolate the genetic causes of cleft lip. The
main reason for the intractability of the problem is that
the probability of expression of the mutation is modified
by many other factors, such as maternal genotype.
Juriloff [14,15] overcame these problems by repeated
backcrossing of the cleft-lip-causing gene, from a strain
of mouse that has naturally occurring cleft lip, into a
non-cleft-lip strain. The congenic strain so produced
carries a 10 centiMorgan region of DNA that segregates
with the cleft-lip phenotype and is located on chromo-
some 11. Some genes that also map to this region include
those encoding retinoic acid receptor o (RARot), Wnt-
3, the nerve growth factor receptor and the thyroid hor-
mone receptor. The Hoxb cluster, also located on
chromosome 11, has recombined with, and is therefore
outside of, the candidate region.
One of the candidate genes, that encoding RARa, is
expressed in migrating neural crest cells, facial mes-
enchyme and epithelium [16], and continues to be
expressed during cytodifferentiation of cartilage and
bone. Current understanding of RARat, however, does
not support a major role for it in the genesis of non-
syndromic cleft lip. First, RARa is not selectively
expressed in regions of the facial prominences where
outgrowth or fusion occurs. Second, genetically engi-
neered mice lacking RARa expression do not show
craniofacial defects [17]. Although the complete absence
of individual RARs may have little effect on embryo
development, it is possible that more subtle mutations
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may have greater effects on gene function. For example,
the RARs are known to dimerize with the related
retinoic acid X receptors (RXRs), and a mutation that
alters receptor dimerization may affect a wider range of
developmental events than a simple null mutation.
Indeed, the simultaneous elimination of several different
types of RAR in one mouse leads to severe defects in the
craniofacial complex, including midline clefts [11].
Finally, Juriloff's congenic mouse data [14,15] suggest the
existence of a second locus that suppresses the expression
of the cleft phenotype. This would explain the hetero-
geneous incidence of cleft lip when individual proven
carriers are bred with each other. In the next few years,
more detailed genetic maps of chromosome 11 will
become available, and the identification of the mutations
responsible for the cleft phenotype will be feasible. The
results from the Juriloff laboratory will certainly advance
research on human cleft lip by focusing efforts on
homologous regions of the human genome.
Genes defective in individuals with craniosynostosis
The final phase of cranial morphogenesis involves the
differentiation of bone, and coordination of growth
between bones. A relatively common problem with bone
growth is the premature fusion of the sutures between
the flat bones of the skull. The incidence of such 'cranio-
synostosis' is 1 in 2 500, and over 100 inherited syn-
dromes manifest this trait. Until recently, the cellular and
genetic basis of craniosynostosis had remained elusive.
Now, however, two groups [18-22] have found that
mutations in FGFR genes are associated with four syn-
dromes that cause craniosynostosis. Crouzon syndrome
features midface hypoplasia, relative mandibular prog-
nathism and shallow orbits, in addition to cranio-
synostosis. Jackson-Weiss, Pfeiffer and Apert syndromes
share many of the same features, but also include syn-
dactyly and other abnormalities in size and shape of the
digits. Each syndrome has been recognized as a distinct
entity, and patients with Crouzon syndrome are not born
into families with Pfeiffer syndrome, and vice versa [21].
Surprisingly, patients with Crouzon, Jackson-Weiss,
Pfeiffer and Apert syndromes have point mutations
affecting a similar region of FGFR-2 (isoform IIIc)
[18,19,21,22]. Moreover, some Crouzon and Pfeiffer
syndrome patients have identical FGFR-2 mutations
[21]. This finding was unsettling for clinical geneticists
who have always believed each syndrome to be distinct.
Further study may reveal other FGFR-2 mutations that
are unique to patients with either syndrome.
Other Pfeiffer syndrome patients have point mutations
affecting the extracellular domain of FGFR-1 [20]. This
observation, that mutations of two different FGF recep-
tors can cause Pfeiffer syndrome, can be reconciled in
two possible ways. The first possible explanation is that,
as the amino-acid residues affected by the mutations
causing both types of syndrome have similar locations in
the third immunoglobulin-like domains of FGFR-1 and
FGFR-2, they may cause similar functional defects of the
two receptors. These domains are involved in determin-
ing the receptors' ligand specificity for various members
of the ever-growing fibroblast growth factor family [23].
The second possible explanation for the similar pheno-
types of the Pfeiffer and Jackson-Weiss syndromes lies in
the observation that, in animal models, FGFR-1 and
FGFR-2 have been shown to have overlapping expres-
sion domains in the limb and head ([8] and my own
group's unpublished data); perhaps these similar expres-
sion patterns are matched by similar developmental roles
for the two receptor types. At present, we have indirect
evidence that functional FGF receptors are important for
the development of the two body regions affected in
Pfeiffer syndrome; some further support for their impor-
tance comes from finding that exogenous FGF-2 and
FGF-4 can stimulate growth of limb and fronto-nasal
mesenchyme ([24-26] and my group's unpublished data).
Despite the compelling genetic data, it is far from estab-
lished that mutations affecting FGFRs cause cranio-
synostosis. For example, mutations affecting another
member of the family, FGFR-3, are associated with
achondroplastic dwarfism, a syndrome that does not
manifest craniosynostosis [27,28]. Furthermore, other
forms of craniosynostosis (such as the Boston type [29])
are associated with mutations affecting a transcription
factor (Msx-2), rather than an FGFR. These findings, in
combination with the large variations in phenotype
between individuals with identical point mutations [21],
make it very likely that other genes modify the effects of
the FGFR gene mutations. At present, we have little evi-
dence that FGFRs are involved in bone morphogenesis
or differentiation, but as a result of the human findings,
research efforts will now be directed along these lines.
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